_山嵛酸甘油酯作为片剂润滑剂的研究.pdfVIP

Activation of human peroxisome proliferator-activated receptor(PPAR) subtypes by pioglitazone [J]. Biochem Biophys Res Commun, 2000, 278(3): 704-711. [3] YANG P J, LI S M, LÜ Y P, et al. Effects of pioglitazone and metformin on vascular endothelial function in patients with 10%40%~50% type 2 diabetes treated with sulfonylureas [J]. Chin J Hosp Pharm(), 2012, 32(21): 1752-1754. [4] GALLE J, KLEOPHAS W, FORST T, et al. Comparison of the effects of pioglitazone versus placebo when given in addition to standard insulin treatment in patients with type 2 diabetes mellitus requiring hemodialysis: results from the pioren study [J]. Nephron Extra, 2012, 2(1):104-114. [5] WU S Y, GENG X Q, WANG L D, et al. Effects of pioglitazone, repaglinide or metformin on blood uric acid and renal function in recent-onset type 2 diabetes [J]. Chin J Mod